1 Departments of Pediatrics and Medical Statistics, University Hospital, Leiden, The Netherlands; the Imperial Cancer Research Fund, Hemopoiesis Research Group, St. Bartholomew's Hospital, London, United Kingdom; and the Department of Pediatrics, Hôpital Necker des Enfants Malades, Paris, France
Objective. To determine the variability and the natural course of children suffering from autosomal recessive osteopetrosis to allow optimal counseling and decision making with respect to therapeutic intervention.
Design. Retrospective and longitudinal evaluation of clinical symptoms and natural course with emphasis on survival and sensoneurologic and hematologic findings.
Setting. Two large referral-based pediatric bone marrow transplantation units in Europe.
Patients. Thirty-three patients with autosomal recessive osteopetrosis admitted to units in Paris and Leiden between 1972 and 1988 were analyzed until last follow-up or the time at which bone marrow transplantation was performed. The great number of patients and unprecedented amount of data make this report one of the single largest clinical studies on autosomal recessive osteopetrosis.
Main results. Ocular involvement occurring at a median age of 2 months was the symptom at initial examination in half of the patients. A striking variability between patients was found. Retinal degeneration was present in three patients and associated generalized neurodegeneration was present in two. The probability of survival until the age of 6 years was about 30% for the group as a whole. The cumulative risk of developing visual or hematologic impairment in the first year of life was about 75% and leveled off afterward. Patients with early hematologic impairment, ie, before 3 months of age, especially when combined with early visual impairment, had a very poor prognosis regarding life expectancy.
Conclusions. Autosomal recessive osteopetrosis seems to be a variable disorder with a poor prognosis, especially in children with early visual and hematologic impairment. Allogeneic bone marrow transplantation remains the only curative approach.
Submitted on March 18, 1993
This article has been cited by other articles:
![]() |
M. K. Johansson, T. J. de Vries, T. Schoenmaker, M. Ehinger, A. C. M. Brun, A. Fasth, S. Karlsson, V. Everts, and J. Richter Hematopoietic stem cell-targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc/oc mice Blood, June 15, 2007; 109(12): 5178 - 5185. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Thomas, A C Elias-Jones, and A V Sridhar A newborn twin with unusual chest radiograph Postgrad. Med. J., November 1, 2006; 82(973): e28 - e28. [Full Text] [PDF] |
||||
![]() |
J. Tolar, S. L. Teitelbaum, and P. J. Orchard Osteopetrosis N. Engl. J. Med., December 30, 2004; 351(27): 2839 - 2849. [Full Text] [PDF] |
||||
![]() |
N H Elcioglu, A Vellodi, and C M Hall Dysosteosclerosis: a report of three new cases and evolution of the radiological findings J. Med. Genet., August 1, 2002; 39(8): 603 - 607. [Full Text] [PDF] |
||||
![]() |
E. Cleiren, O. Benichou, E. Van Hul, J. Gram, J. Bollerslev, F. R. Singer, K. Beaverson, A. Aledo, M. P. Whyte, T. Yoneyama, et al. Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene Hum. Mol. Genet., December 1, 2001; 10(25): 2861 - 2867. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sobacchi, A. Frattini, P. Orchard, O. Porras, I. Tezcan, M. Andolina, R. Babul-Hirji, I. Baric, N. Canham, D. Chitayat, et al. The mutational spectrum of human malignant autosomal recessive osteopetrosis Hum. Mol. Genet., August 1, 2001; 10(17): 1767 - 1773. [Abstract] [Full Text] [PDF] |
||||
![]() |
C J Wilson and A Vellodi Personal practice: Autosomal recessive osteopetrosis: diagnosis, management, and outcome Arch. Dis. Child., November 1, 2000; 83(5): 449 - 452. [Full Text] |
||||
![]() |
U. Kornak, A. Schulz, W. Friedrich, S. Uhlhaas, B. Kremens, T. Voit, C. Hasan, U. Bode, T. J. Jentsch, and C. Kubisch Mutations in the a3 subunit of the vacuolar H+-ATPase cause infantile malignant osteopetrosis Hum. Mol. Genet., August 12, 2000; 9(13): 2059 - 2063. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Srinivasan, M. Abinun, A. J Cant, K. Tan, A. Oakhill, and C. G Steward Malignant infantile osteopetrosis presenting with neonatal hypocalcaemia Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2000; 83(1): 21F - 23. [Abstract] [Full Text] |
||||
![]() |
N. Burt, G. R. Haynes, and M. K. Bailey Patients with Malignant Osteopetrosis Are at High Risk of Anesthetic Morbidity and Mortality Anesth. Analg., June 1, 1999; 88(6): 1292 - 1292. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Abinun, T Newson, P W Rowe, T J Flood, and A J Cant Importance of neurological assessment before bone marrow transplantation for osteopetrosis Arch. Dis. Child., March 1, 1999; 80(3): 273 - 274. [Abstract] [Full Text] |
||||
![]() |
R. I. Parker and P. L. Nguyen Case 37-1994- A Newborn Boy with Petechiae, Hepatosplenomegaly, Leukocytosis, and Thrombocytopenia N. Engl. J. Med., October 13, 1994; 331(15): 1005 - 1012. [Full Text] |
||||